Trial Search Results

Community Health Workers and Precision Medicine

The purpose of this randomized controlled trial is to evaluate whether a trained community health worker (CHW) who engages with newly diagnosed patients after a diagnosis of cancer can effectively improve knowledge and receipt of evidence-based precision medicine cancer care services among low-income and minority patients.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Stanford University

Collaborator: California Initiative to Advance Precision Medicine

Stanford Investigator(s):


  • Behavioral: Community Health Worker Support




Inclusion Criteria:

   - Newly diagnosed patients with a cancer diagnosis.

   - Patients with any relapse or progressive disease (any cancer diagnosis) as identified
   by imaging or biopsy and confirmed by a physician.

   - The patients must be 18 years or older.

   - Patients must have the capacity to verbally consent in English or Spanish.

   - Patients must be racial/ethnic minorities OR low-income status OR public insurance
   (Medi-Cal or other) OR have health insurance provided by an agricultural company OR be

Exclusion Criteria:

   - Patients under 18 years of age.

   - Inability to consent to the study due to lack of capacity as documented by the
   referring physician.

   - Patients without a newly diagnosed malignancy or patients without relapse of disease.

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study


Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Manali I Patel, MD, MPH, MS